Research & Development
Academic Report
Introducing arginine residues into scFv in CAR-T cells shows promising antitumor effects
| Presented by: | Shingo Maeta1), Atsushi Fukunaga1), Yuriko Egashira1), Yasushi Akahori2), Linan Wang2), Naohiro Seo2), Yusuke Atarashi1), Daisuke Ejima1), Hiroshi Fujiwara2), Hiroshi Shiku2) |
| 1) Bio-Diagnostic Reagent Technology Center, Sysmex Corporation 2) Department of Personalized Cancer Immunotherapy, Graduate School of Medicine, Mie University |
|
|
Journal:
|
Molecular Therapy
|
|
DOI:
|
10.1016/j.ymthe.2025.12.006
|
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.